Cascadian Therapeutics Inc (USA) Stock

Stocks

04/01/18	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	GL
02/01/18	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	GL
13/12/17	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	GL
08/12/17	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	GL
09/11/17	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0.50%	-	-	0
WUXI APPTEC CO., LTD.	-1.90%	+3.12%	+81.70%	+110.88%	73.45B
ARGENX SE	+0.87%	+15.32%	+56.99%	+95.59%	62.99B
INSMED INCORPORATED	+1.71%	-1.22%	+2.71%	+501.29%	28.05B
WUXI BIOLOGICS (CAYMAN) INC.	+4.26%	+10.35%	+64.76%	+26.76%	25.42B
BIONTECH SE	+21.96%	+21.98%	+1.54%	+2.50%	23.3B
GENMAB A/S	+2.28%	+5.65%	+42.00%	-12.34%	19.45B
PHARMAESSENTIA CORPORATION	0.00%	-2.78%	+247.46%	+423.83%	18.16B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.02%	+6.09%	+29.35%	+555.88%	16.53B
EXELIXIS, INC.	+2.39%	+7.96%	+44.96%	+157.77%	13.16B
Average	+3.91%	+5.80%	+63.50%	+206.91%	31.17B
Weighted average by Cap.	+2.83%	+6.43%	+63.23%	+170.01%

Employees

Sector